DiaMedica Reports $11.3 Million Q3 Net Loss; Cash Runway Into Q4 2027

DiaMedica reported a third-quarter 2026 net loss of $11.3 million, compared with $8.6 million a year earlier, as research and development expenses increased. Cash, cash equivalents and short-term investments totaled $34.9 million at September 30, and the company expects to fund planned studies and…